Trial Profile
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone
- Indications Central retinal vein occlusion
- Focus Therapeutic Use
- 25 Sep 2015 New trial record